<DOC>
	<DOCNO>NCT02423187</DOCNO>
	<brief_summary>To investigate safety efficacy long-term combination therapy rabeprazole low-dose aspirin .</brief_summary>
	<brief_title>Rabeprazole Specific Clinical Experience Investigation Long-term Combination Therapy With Low-dose Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients take longterm lowdose aspirin prevention thrombus/embolism start administration rabeprazole ( include patient start lowdose aspirin day start administration rabeprazole ) . 2 . Patients history gastric/duodenal ulcer . 3 . Patients require longterm use rabeprazole prevention recurrence gastric/duodenal ulcer induce lowdose aspirin . Exclusion criterion : 1 . Patients gastric/duodenal ulcer start administration rabeprazole . 2 . Patients active upper gastrointestinal bleed start administration rabeprazole . 3 . Patients contraindication rabeprazole .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Stomach ulcer</keyword>
	<keyword>Duodenal ulcer</keyword>
	<keyword>Rabeprazole</keyword>
	<keyword>Recurrence</keyword>
</DOC>